/
No Comments
NPPA has capped trade margins on 137 anti-cancer formulations at 30%, potentially reducing retail prices by up to 70% from November 9.
NPPA has capped trade margins on 137 anti-cancer formulations at 30%, potentially reducing retail prices by up to 70% from November 9.
Hiring demand in India’s pharma and life sciences sector rose 20% in April-September, led by mid-career professionals and specialised roles.
NIPER Raebareli and AstraZeneca India will support 25 emerging clinical trial sites under a partnership aligned with the government’s Biopharma SHAKTI initiative.
Scientists and biotech researchers working on pharmaceutical and MedTech innovation as India expands R&D support under the PRIP scheme.
IHH Healthcare plans to raise its Fortis Healthcare stake to 51% and expand capacity to around 10,000 beds by 2031. Pasted text
Crisil expects pharmaceutical sector revenue to grow 11–13% this fiscal year, led by exports and domestic demand.
Maharishi Ayurveda is investing €5 million in a European wellness, education and research expansion centred on a new facility in the Netherlands.
Pharmaceutical professionals conduct quality-control work at an Indian bioequivalence research facility.
A pharmaceutical research and healthcare setting representing Sun Pharma's agreement with the US government.
Argentina commits to reducing regulatory barriers for Indian pharmaceutical companies, opening new opportunities for India's growing pharma exports.
India Business & Trade is a national media platform decoding the ideas, decisions and shifts shaping India’s growth story—across plicy, business, global commerce and a rapidly evolving marketplace.
India Business & Trade
M-62, Saket, New Delhi-110064, India
Stay ahead in the dynamic world of trade and commerce with India Business & Trade’s weekly newsletter.
Copyright © 2026 India Business & Trade. All Rights Reserved
